The dapoxetine drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Dapoxetine drug is used for the treatment of premature ejaculation. This drug is found efficient in the trials done to increase ejaculatory latency. This drug is undergoing trials and is yet not approved by FDA. This drug is a type of serotonin reuptake inhibitor. Several clinical trials have been done on this drug yet experts are of the view that this drug has less chance of getting approved by medical agencies. Major reasons for this include undesirable side effects which are seen in the body after long-term use. The working mechanism of this drug in the body is inhibition of neuronal reuptake of serotonin. The Central ejaculatory neural circuit mainly has two areas- spinal and cerebral. These together form a highly interconnected network. Sympathetic, parasympathetic, and somatic spinal centers are majorly responsible for the physiologic events that are seen during the ejaculation process. Scientific studies and experiments have shown that the serotonin hormone (5-HT) found in the body acts as a mood stabilizer. This hormone is responsible for a healthy sleeping pattern that the body follows. Serotonin hormone acts as an inhibitor in the ejaculation process.
A full report of Global Dapoxetine Drug Market is available at:https://orionmarketreports.com/global-dapoxetine-drug-market/109562/
Premature ejaculation is a condition in which a male human during the process of sexual intercourse ejaculates soon. This condition is quite common these days in almost all parts of the world. This condition occurs when in some or every intercourse, the male ejaculates in less than one minute. Premature ejaculation leads to a feeling of self-doubt. Many people suffering from this ailment with time feel stressed and frustrated. According to health experts, the primary reasons that lead to premature ejaculation are psychological and biological factors. Neurotransmitters are brain chemicals and their abnormal behavior is also a cause of premature ejaculation.
According to an article in Medscape, the prevalence rate of premature ejaculation in the United States is around 30-70% in males. The prevalence rate of premature ejaculation in Europe is around 22%.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Disease
- By Distribution Channel
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape-Sun Pharmaceutical Industries Ltd., Emcure Pharmaceuticals, Johnson & Johnson Private Limited, Sichuan Kelun Pharmaceutical Co., Ltd.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Dapoxetine Drug Market Report by Segment
By Disease
- Premature Ejaculation
- Others
By Distribution Channel
- Online
- Retail Store
- Hospital Pharmacy
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
